$6.84
00.00%
Pre-Market: 4:00 PM EDT
15 minutes delayed
Ironwood Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Ironwood Pharmaceuticals using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
IRWD | Ironwood Pharmaceuticals | -$6.71 | $0.15 | — | — | $107.38M | $107.00M | — | — | 08/06/2024 | Get Alert |
IRWD | Ironwood Pharmaceuticals | $0.25 | $0.20 | -$0.02 | -110.00% | $104.06M | $106.30M | $74.88M | -29.56% | 05/09/2024 | Get Alert |
IRWD | Ironwood Pharmaceuticals | $0.27 | $0.21 | $0.00 | -100.00% | $107.20M | $117.48M | $117.55M | 0.06% | 02/15/2024 | Get Alert |
IRWD | Ironwood Pharmaceuticals | $0.28 | $0.16 | $0.12 | -25.00% | $108.64M | $112.89M | $113.74M | 0.75% | 11/09/2023 | Get Alert |
IRWD | Ironwood Pharmaceuticals | $0.21 | $0.25 | $0.31 | 24.00% | $97.23M | $103.71M | $107.38M | 3.54% | 08/08/2023 | Get Alert |
IRWD | Ironwood Pharmaceuticals | $0.21 | $0.24 | $0.25 | 4.17% | $97.53M | $100.41M | $104.06M | 3.64% | 05/04/2023 | Get Alert |
IRWD | Ironwood Pharmaceuticals | $0.27 | $0.27 | $0.27 | 0.00% | $117.13M | $110.84M | $107.20M | -3.28% | 02/16/2023 | Get Alert |
IRWD | Ironwood Pharmaceuticals | $0.33 | $0.26 | $0.28 | 7.69% | $103.75M | $109.11M | $108.64M | -0.43% | 11/03/2022 | Get Alert |
IRWD | Ironwood Pharmaceuticals | $0.34 | $0.30 | $0.21 | -30.00% | $104.03M | $103.51M | $97.23M | -6.07% | 08/04/2022 | Get Alert |
IRWD | Ironwood Pharmaceuticals | $0.24 | $0.25 | $0.21 | -16.00% | $88.84M | $94.35M | $97.53M | 3.37% | 05/05/2022 | Get Alert |
IRWD | Ironwood Pharmaceuticals | $0.36 | $0.35 | $0.27 | -22.86% | $116.68M | $109.87M | $117.13M | 6.61% | 02/17/2022 | Get Alert |
IRWD | Ironwood Pharmaceuticals | $0.23 | $0.31 | $0.33 | 6.45% | $103.47M | $105.40M | $103.75M | -1.57% | 11/04/2021 | Get Alert |
IRWD | Ironwood Pharmaceuticals | $0.16 | $0.22 | $0.34 | 54.55% | $89.43M | $93.10M | $104.03M | 11.74% | 08/05/2021 | Get Alert |
IRWD | Ironwood Pharmaceuticals | $0.04 | $0.21 | $0.24 | 14.29% | $79.94M | $95.20M | $88.84M | -6.68% | 05/06/2021 | Get Alert |
IRWD | Ironwood Pharmaceuticals | $0.30 | $0.29 | $0.36 | 24.14% | $126.30M | $111.95M | $116.68M | 4.23% | 02/17/2021 | Get Alert |
IRWD | Ironwood Pharmaceuticals | $0.40 | $0.15 | $0.23 | 53.33% | $131.17M | $95.96M | $103.47M | 7.82% | 11/05/2020 | Get Alert |
IRWD | Ironwood Pharmaceuticals | $0.10 | $0.09 | $0.16 | 77.78% | $102.22M | $86.24M | $89.43M | 3.70% | 08/06/2020 | Get Alert |
IRWD | Ironwood Pharmaceuticals | -$0.26 | $0.05 | $0.04 | -20.00% | $68.73M | $78.66M | $79.94M | 1.63% | 05/06/2020 | Get Alert |
IRWD | Ironwood Pharmaceuticals | -$0.02 | $0.24 | $0.30 | 25.00% | $130.69M | $111.85M | $126.30M | 12.92% | 02/13/2020 | Get Alert |
IRWD | Ironwood Pharmaceuticals | -$0.38 | $0.10 | $0.40 | 300.00% | $65.69M | $96.38M | $131.17M | 36.09% | 10/31/2019 | Get Alert |
IRWD | Ironwood Pharmaceuticals | -$0.28 | -$0.03 | $0.10 | 433.33% | $81.11M | $89.84M | $102.22M | 13.77% | 07/30/2019 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-09 | $-0.02 | $0.20 | -110.0 % |
Dec 2023 | 2024-02-15 | $0 | $0.21 | -100.0 % |
Sep 2023 | 2023-11-09 | $0.12 | $0.16 | -25.0 % |
Jun 2023 | 2023-08-08 | $0.31 | $0.25 | 24.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-09 | $74.88M | $106.30M | -29.6 % |
Dec 2023 | 2024-02-15 | $117.55M | $117.48M | 0.06 % |
Sep 2023 | 2023-11-09 | $113.74M | $112.89M | 0.75 % |
Jun 2023 | 2023-08-08 | $107.38M | $103.71M | 3.54 % |
Ironwood Pharmaceuticals (IRWD) is scheduled to report earnings on August 6, 2024. The last reported earnings were for reported on May 9, 2024 for Q1.
The Actual EPS was $-0.02, which missed the estimate of $0.20.
The Actual Revenue was $74.9M, which missed the estimate of $106.3M.
Browse earnings estimates, EPS, and revenue on all stocks.